Rheumatological manifestations occurring in patients with diabetes mellitus

References

• Crispin JC, Alcocer-Varela J. Rheumatologic manifestations of diabetes mellitus. Am J Med 2003;114:753–7.
   PubMed Web of Science ®Google Scholar
• Arkkila PE, Gautier JF. Musculoskeletal disorders in diabetes mellitus: an update. Best Pract Res Clin Rheumatol 2003;17: 945–70.
   PubMed Web of Science ®Google Scholar
• Lebiedz-Odrobina D, Kay J. Rheumatic manifestations of diabetes mellitus. Rheum Dis Clin North Am 2010;36:681–99.
   PubMed Web of Science ®Google Scholar
• Smith LL, Burnet SP, McNeil JD. Musculoskeletal manifestations of diabetes mellitus. Br J Sports Med 2003;37:30–5.
   PubMed Web of Science ®Google Scholar
• Buckingham B, Reiser KM. Relationship between the content of lysyl oxidase-dependent cross-links in skin collagen, nonenzymatic glycosylation, and long-term complications in type I diabetes mellitus. J Clin Invest 1990;86:1046–54.
   PubMed Web of Science ®Google Scholar
• Abate M, Schiavone C, Pelotti P, Salini V. Limited joint mobility in diabetes and ageing: recent advances in pathogenesis and therapy. Int J Immunopathol Pharmacol 2010;23:997–1003.
   PubMed Web of Science ®Google Scholar
• Rosenbloom AL, Silverstein JH. Connective tissue and joint disease in diabetes mellitus. Endocrinol Metab Clin North Am 1996;25:473–83.
   PubMed Web of Science ®Google Scholar
• Cárdenas-León M, Díaz-Díaz E, Argüelles-Medina R, Sánchez-Canales P, Díaz-Sánchez V, Larrea F. Glycation and protein crosslinking in the diabetes and ageing pathogenesis. Rev Invest Clin 2009;61:505–20.
   PubMedGoogle Scholar
• Baumhauer JF, O’Keefe RJ, Schon LC, Pinzur MS. Cytokine-induced osteoclastic bone resorption in Charcot arthropathy: an immunohistochemical study. Foot Ankle Int 2006;27:797–800.
   PubMed Web of Science ®Google Scholar
• Ryu JD, Kirpalani PA, Kim JM, Nam KH, Han CW, Han SH. Expression of vascular endothelial growth factor and angiogenesis in the diabetic frozen shoulder. J Shoulder Elbow Surg 2006;15:679–85.
   PubMed Web of Science ®Google Scholar
• Pal B, Anderson J, Dick WC, Griffiths ID. Limitation of joint mobility and shoulder capsulitis in insulin- and non-insulin-dependent diabetes mellitus. Br J Rheumatol 1986;25:147–51.
   PubMedGoogle Scholar
• Tasto JP, Elias DW. Adhesive capsulitis. Sports Med Arthrosc 2007;15:216–21.
   PubMed Web of Science ®Google Scholar
• Cagliero E, Apruzzese W, Perlmutter GS, Nathan DM. Musculoskeletal disorders of the hand and shoulder in patients with diabetes mellitus. Am J Med 2002;112:487–90.
   PubMed Web of Science ®Google Scholar
• Arkkila PE, Kantola IM, Viikari JS, Rönnemaa T. Shoulder capsulitis in type I and II diabetic patients: association with diabetic complications and related diseases. Ann Rheum Dis 1996;55:907–14.
   PubMed Web of Science ®Google Scholar
• Fisher L, Kurtz A, Shipley M. Association between cheiroarthropathy and frozen shoulder in patients with insulin-dependent diabetes mellitus. Br J Rheumatol 1986;25:141–6.
   PubMedGoogle Scholar
• Morén-Hybbinette I, Moritz U, Scherstén B. The clinical picture of the painful diabetic shoulder – natural history, social consequences and analysis of concomitant hand syndrome. Acta Med Scand 1987;221:73–82.
   PubMedGoogle Scholar
• Thomas SJ, McDougall C, Brown ID, Jaberoo MC, Stearns A, Ashraf R, . Prevalence of symptoms and signs of shoulder problems in people with diabetes mellitus. J Shoulder Elbow Surg 2007;16:748–51.
   PubMed Web of Science ®Google Scholar
• Mathew AJ, Nair JB, Pillai SS. Rheumatic-musculoskeletal manifestations in type 2 diabetes mellitus patients in south India. Int J Rheum Dis 2011;14:55–60.
   PubMed Web of Science ®Google Scholar
• Aydeniz A, Gursoy S, Guney E. Which musculoskeletal complications are most frequently seen in type 2 diabetes mellitus? J Int Med Res 2008;36:505–11.
   PubMed Web of Science ®Google Scholar
• Tighe CB, Oakley WS Jr. The prevalence of a diabetic condition and adhesive capsulitis of the shoulder. South Med J 2008;101:591–5.
   PubMed Web of Science ®Google Scholar
• Milgrom C, Novack V, Weil Y, Jaber S, Radeva-Petrova DR, Finestone A. Risk factors for idiopathic frozen shoulder. Isr Med Assoc J 2008;10:361–4.
   PubMed Web of Science ®Google Scholar
• Loos B, Puschkin V, Horch RE. 50 years experience with Dupuytren’s contracture in the Erlangen University Hospital – a retrospective analysis of 2919 operated hands from 1956 to 2006. BMC Musculoskelet Disord 2007;8:60.
   PubMed Web of Science ®Google Scholar
• Forsman M, Pääkkönen V, Tjäderhane L, Vuoristo J, Kallioinen L, Salo T, . The expression of myoglobin and ROR2 protein in Dupuytren’s disease. J Surg Res 2008;146:271–5.
   PubMed Web of Science ®Google Scholar
• Norotte G, Apoil A, Travers V. A ten years follow-up of the results of surgery for Dupuytren’s disease. A study of fifty-eight cases. Ann Chir Main 1988;7:277–81.
   PubMedGoogle Scholar
• Noble J, Heathcote JG, Cohen H. Diabetes mellitus in the aetiology of Dupuytren’s disease. J Bone Joint Surg Br 1984;66:322–5.
   PubMedGoogle Scholar
• Larkin JG, Frier BM. Limited joint mobility and Dupuytren’s contracture in diabetic, hypertensive, and normal populations. Br Med J (Clin Res Ed) 1986;292:1494.
   PubMedGoogle Scholar
• Reilly RM, Stern PJ, Goldfarb CA. A retrospective review of the management of Dupuytren’s nodules. J Hand Surg Am 2005;30:1014–18.
   PubMedGoogle Scholar
• Tripoli M, Cordova A, Moschella F. The ‘Jacobsen flap’ technique: a safe, simple surgical procedure to treat Dupuytren disease of the little finger in advanced stage. Tech Hand Up Extrem Surg 2010;14:173–7.
   PubMedGoogle Scholar
• van Rijssen AL, Werker PM. Percutaneous needle fasciotomy in Dupuytren’s disease. J Hand Surg Br 2006;31:498–501.
   PubMedGoogle Scholar
• Hurst LC, Badalamente MA, Hentz VR, Hotchkiss RN, Kaplan FT, Meals RA, . CORD I Study Group. Injectable collagenase clostridium histolyticum for Dupuytren’s contracture. N Engl J Med 2009;361:968–79.
   PubMed Web of Science ®Google Scholar
• Watt AJ, Curtin CM, Hentz VR. Collagenase injection as nonsurgical treatment of Dupuytren’s disease: 8-year follow-up. J Hand Surg Am 2010;35:534–9, 539.e1.
   PubMedGoogle Scholar
• Gilpin D, Coleman S, Hall S, Houston A, Karrasch J, Jones N. Injectable collagenase Clostridium histolyticum: a new nonsurgical treatment for Dupuytren’s disease. J Hand Surg Am 2010;35: 2027–38.e1.
   PubMed Web of Science ®Google Scholar
• Burke FD, Proud G, Lawson IJ, McGeoch KL, Miles JN. An assessment of the effects of exposure to vibration, smoking, alcohol and diabetes on the prevalence of Dupuytren’s disease in 97,537 miners. J Hand Surg Eur Vol 2007;32:400–6.
   PubMedGoogle Scholar
• Geoghegan JM, Forbes J, Clark DI, Smith C, Hubbard R. Dupuytren’s disease risk factors. J Hand Surg Br 2004;29:423–6.
   PubMedGoogle Scholar
• Zerajic D, Finsen V. Dupuytren’s disease in Bosnia and Herzegovina. An epidemiological study. BMC Musculoskelet Disord 2004;5:10.
   PubMed Web of Science ®Google Scholar
• Arkkila PE, Kantola IM, Viikari JS. Limited joint mobility in non-insulin-dependent diabetic (NIDDM) patients: correlation to control of diabetes, atherosclerotic vascular disease, and other diabetic complications. J Diabetes Complications 1997;11:208–17.
   PubMed Web of Science ®Google Scholar
• Al-Matubsi HY, Hamdan F, Alhanbali OA, Oriquat GA, Salim M. Diabetic hand syndromes as a clinical and diagnostic tool for diabetes mellitus patients. Diabetes Res Clin Pract 2011;94:225–9.
   PubMed Web of Science ®Google Scholar
• Rosenbloom AL, Silverstein JH, Lezotte DC, Richardson K, McCallum M. Limited joint mobility in childhood diabetes mellitus indicates increased risk for microvascular disease. N Engl J Med 1981;305:191–4.
   PubMed Web of Science ®Google Scholar
• Arkkila PE, Kantola IM, Viikari JS. Limited joint mobility in type 1 diabetic patients: correlation to other diabetic complications. J Intern Med 1994;236:215–23.
   PubMed Web of Science ®Google Scholar
• Frost D, Beischer W. Limited joint mobility in type 1 diabetic patients: associations with microangiopathy and subclinical macroangiopathy are different in men and women. Diabetes Care 2001;24:95–9.
   PubMed Web of Science ®Google Scholar
• Garg SK, Chase HP, Marshall G, Jackson WE, Holmes D, Hoops S, . Limited joint mobility in subjects with insulin dependent diabetes mellitus: relationship with eye and kidney complications. Arch Dis Child 1992;67:96–9.
   PubMed Web of Science ®Google Scholar
• Clarke CF, Piesowicz AT, Spathis GS. Limited joint mobility in children and adolescents with insulin dependent diabetes mellitus. Ann Rheum Dis 1990;49:236–7.
   PubMed Web of Science ®Google Scholar
• Lindsay JR, Kennedy L, Atkinson AB, Bell PM, Carson DJ, McCance DR, . Reduced prevalence of limited joint mobility in type 1 diabetes in a UK clinic population over a 20-year period. Diabetes Care 2005;28:658–61.
   PubMed Web of Science ®Google Scholar
• Savaş S, Köroğlu BK, Koyuncuoğlu HR, Uzar E, Celik H, Tamer NM. The effects of the diabetes related soft tissue hand lesions and the reduced hand strength on functional disability of hand in type 2 diabetic patients. Diabetes Res Clin Pract 2007;77:77–83.
   PubMed Web of Science ®Google Scholar
• Ramchurn N, Mashamba C, Leitch E, Arutchelvam V, Narayanan K, Weaver J, . Upper limb musculoskeletal abnormalities and poor metabolic control in diabetes. Eur J Intern Med 2009;20:718–21.
   PubMed Web of Science ®Google Scholar
• Donato G, Galasso O, Valentino P, Conforti F, Zuccala V, Russo E, . Pathological findings in subsynovial connective tissue in idiopathic carpal tunnel syndrome. Clin Neuropathol 2009;28:129–35.
   PubMed Web of Science ®Google Scholar
• Pierce CW, Tucci MA, Lindley S, Freeland A, Benghuzzi HA. Connective tissue growth factor (CTGF) expression in the tenosynovium of patients with carpal tunnel syndrome – biomed 2009. Biomed Sci Instrum 2009;45:30–5.
   PubMedGoogle Scholar
• de Krom MC, Knipschild PG, Kester AD, Thijs CT, Boekkooi PF, Spaans F. Carpal tunnel syndrome: prevalence in the general population. J Clin Epidemiol 1992;45:373–6.
   PubMed Web of Science ®Google Scholar
• Atroshi I, Gummesson C, Johnsson R, Ornstein E, Ranstam J, Rosen I. Prevalence of carpal tunnel syndrome in a general population. J Am Med Assoc 1999;282:153–8.
   PubMed Web of Science ®Google Scholar
• Katz JN, Simmons BP. Clinical practice. Carpal tunnel syndrome. N Engl J Med 2002;346:1807–12.
   PubMed Web of Science ®Google Scholar
• Salaffi F, De Angelis R, Grassi W; MArche Pain Prevalence; INvestigation Group (MAPPING) study. Prevalence of musculoskeletal conditions in an Italian population sample: results of a regional community-based study. I. The MAPPING study. Clin Exp Rheumatol 2005;23:819–28
   PubMed Web of Science ®Google Scholar
• Alvarez-Nemegyei J, Pelaez-Ballestas I, Rodríguez-Amado J, Sanin LH, Garcia-Garcia C, Garza-Elizondo MA, . Prevalence of rheumatic regional pain syndromes in adults from Mexico: a community survey using COPCORD for screening and syndrome-specific diagnostic criteria. J Rheumatol Suppl 2011;86:15–20.
   PubMedGoogle Scholar
• Geoghegan JM, Clark DI, Bainbridge LC, Smith C, Hubbard R. Risk factors in carpal tunnel syndrome. J Hand Surg Br 2004;29:315–20.
   PubMedGoogle Scholar
• de Rijk MC, Vermeij FH, Suntjens M, van Doorn PA. Does a carpal tunnel syndrome predict an underlying disease? J Neurol Neurosurg Psychiatry 2007;78:635–7.
   PubMed Web of Science ®Google Scholar
• Gulliford MC, Latinovic R, Charlton J, Hughes RA. Increased incidence of carpal tunnel syndrome up to 10 years before diagnosis of diabetes. Diabetes Care 2006;29:1929–30.
   PubMed Web of Science ®Google Scholar
• Plastino M, Fava A, Carmela C, De Bartolo M, Ermio C, Cristiano D, . Insulin resistance increases risk of carpal tunnel syndrome: a case-control study. J Peripher Nerv Syst 2011;16:186–90.
   PubMed Web of Science ®Google Scholar
• Singh R, Gamble G, Cundy T. Lifetime risk of symptomatic carpal tunnel syndrome in Type 1 diabetes. Diabet Med 2005; 22:625–30.
   PubMed Web of Science ®Google Scholar
• Perkins BA, Olaleye D, Bril V. Carpal tunnel syndrome in patients with diabetic polyneuropathy. Diabetes Care 2002;25:565–9.
   PubMed Web of Science ®Google Scholar
• Thomsen NO, Cederlund R, Rosén I, Björk J, Dahlin LB. Clinical outcomes of surgical release among diabetic patients with carpal tunnel syndrome: prospective follow-up with matched controls. J Hand Surg Am 2009;34:1177–87.
   PubMed Web of Science ®Google Scholar
• Thomsen NO, Rosén I, Dahlin LB. Neurophysiologic recovery after carpal tunnel release in diabetic patients. Clin Neurophysiol 2010;121:1569–73.
   PubMed Web of Science ®Google Scholar
• Frykberg RG, Zgonis T, Armstrong DG, Driver VR, Giurini JM, Kravitz SR, . Diabetic foot disorders. A clinical practice guideline (2006 revision). J Foot Ankle Surg 2006;45:S1–66.
   PubMedGoogle Scholar
• Gouveri E, Papanas N. Charcot osteoarthropathy in diabetes: a brief review with an emphasis on clinical practice. World J Diabetes 2011;2:59–65.
   PubMedGoogle Scholar
• Tomas MB, Patel M, Marwin SE, Palestro CJ. The diabetic foot. Br J Radiol 2000;73:443–50.
   PubMed Web of Science ®Google Scholar
• Petrova NL, Foster AV, Edmonds ME. Difference in presentation of Charcot osteoarthropathy in type 1 compared with type 2 diabetes. Diabetes Care 2004;27:1235–6.
   PubMed Web of Science ®Google Scholar
• Stuck RM, Sohn MW, Budiman-Mak E, Lee TA, Weiss KB. Charcot arthropathy risk elevation in the obese diabetic population. Am J Med 2008;121:1008–14.
   PubMed Web of Science ®Google Scholar
• Frykberg RG, Mendeszoon E. Management of the diabetic Charcot foot. Diabetes Metab Res Rev 2000;16(Suppl 1):S59–65.
   Google Scholar
• Lambert AP, Close CF. Charcot neuroarthropathy of the wrist in type 1 diabetes. Diabetes Care 2005;28:984–5.
   PubMed Web of Science ®Google Scholar
• Feldman MJ, Becker KL, Reefe WE, Longo A. Multiple neuropathic joints, including the wrist, in a patient with diabetes mellitus. J Am Med Assoc 1969;209:1690–2.
   Web of Science ®Google Scholar
• Bayne O, Lu EJ. Diabetic Charcot’s arthropathy of the wrist. Case report and literature review. Clin Orthop Relat Res 1998;357:122–6.
   Google Scholar
• Wrobel M, Szymborska-Kajanek A, Skiba M, Karasek D, Gorska J, Wittek A, . Charcot’s joint of the wrist in type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes 2007;115:55–7.
   PubMed Web of Science ®Google Scholar
• Naqvi A, Cuchacovich R, Saketkoo L, Espinoza LR. Acute Charcot arthropathy successfully treated with pamidronate: long-term follow-up. Am J Med Sci 2008;335:145–8.
   PubMed Web of Science ®Google Scholar
• Pakarinen TK, Laine HJ, Mäenpää H, Mattila P, Lahtela J. The effect of zoledronic acid on the clinical resolution of Charcot neuroarthropathy: a pilot randomized controlled trial. Diabetes Care 2011;34:1514–16.
   PubMed Web of Science ®Google Scholar
• Petrova NL, Edmonds ME. Charcot neuro-osteoarthropathy – current standards. Diabetes Metab Res Rev 2008;24(Suppl 1):S58–61.
   Google Scholar
• Sarzi-Puttini P, Atzeni F. New developments in our understanding of DISH (diffuse idiopathic skeletal hyperostosis). Curr Opin Rheumatol 2004;16:287–92.
   PubMed Web of Science ®Google Scholar
• Kiss C, Szilágyi M, Paksy A, Poór G. Risk factors for diffuse idiopathic skeletal hyperostosis: a case-control study. Rheumatology (Oxford) 2002;41:27–30.
   PubMed Web of Science ®Google Scholar
• Resnick D, Niwayama G. Radiographic and pathologic features of spinal involvement in diffuse idiopathic skeletal hyperostosis (DISH). Radiology 1976;119:559–68.
   PubMed Web of Science ®Google Scholar
• Julkunen H, Heinonen OP, Knekt P, Maatela J. The epidemiology of hyperostosis of the spine together with its symptoms and related mortality in a general population. Scand J Rheumatol 1975;4:23–7.
   PubMed Web of Science ®Google Scholar
• Utsinger PD. Diffuse idiopathic skeletal hyperostosis. Clin Rheum Dis 1985;11:325–51.
   PubMedGoogle Scholar
• Mader R, Novofestovski I, Adawi M, Lavi I. Metabolic syndrome and cardiovascular risk in patients with diffuse idiopathic skeletal hyperostosis. Semin Arthritis Rheum 2009;38:361–5.
   PubMed Web of Science ®Google Scholar
• Sencan D, Elden H, Nacitarhan V, Sencan M, Kaptanoglu E. The prevalence of diffuse idiopathic skeletal hyperostosis in patients with diabetes mellitus. Rheumatol Int 2005;25:518–21.
   PubMed Web of Science ®Google Scholar
• Mader R, Lavi I. Diabetes mellitus and hypertension as risk factors for early diffuse idiopathic skeletal hyperostosis (DISH). Osteoarthritis Cartilage 2009;17:825–8.
   PubMed Web of Science ®Google Scholar
• Ray S, Datta AK, Sinhamahapatra P, Ray I, Mukhopadhyay P, Dasgupta S. Prevalence of rheumatic conditions in patients with diabetes mellitus in a tertiary care hospital. J Indian Med Assoc 2011;109:74–8.
   PubMedGoogle Scholar